If you’re interested in interventional MRI (iMRI) and how it’s shaping the future of image-guided therapy, check out our recent article:
“The Spectrum of Interventional MRI”
📖 Read here: https://t.co/h0aqAy3dJ4
https://t.co/6KzvAedswG
@MayoRadiology
#AUA25 is only 8 days away and if you haven't started planning your schedule yet, what are you waiting for?!? Thank you @RSanchez_Salas for talking about focal therapy programming. Click the link to start building your schedule now!
https://t.co/otBHuzIjCM
Registration for the 2025 Innovation Nexus Conference is now open! ✈️ Join us in Las Vegas to ignite urologic discovery like never before!
Register today ➡️ https://t.co/VKcYPNbTog
🚀 Early-Bird Registration for the Imperial Prostate & Focal Therapy Society Masterclass 2025 is open! #ipftsmasterclass25
📍Friday 11 April - Saturday 12 April 2025
📍South Kensington, London UK
🎟️ https://t.co/gTZ7wHwMxH
In a 🇬🇧 first, the team @AlderHey, led by consultants Miss Fiona McAndrew & Miss Kaylie Hughes, treated kidney stone pts using a 6.3Fr single-use fURS. The small size of the scope was key, marking a significant step forward in paediatric urology.
#notsoHugeMed@ShenZhenHugeMed
FT is a promising treatment option for limited volume prostate cancer that aims to treat the cancer while preserving quality of life, but does it live up to its hype? In @pcan_journal, we comprehensively review outcomes of established FT modalities - HIFU, IRE and Cryotherapy, and identify the scientific gaps that need to be bridged so that we can bring FT safely to our patients. https://t.co/4cGRN8GNG3
@focalsociety@ArmandoStabile@Lara__Rodriguez
6.3F ureteroscope from Hugemed. That’s the scope tip compared to a 6F ureteral access catheter. WIRELESS URS with Stent Omission will go primetime! @UMichUrology@caseydauw
Our customers asked – so we delivered! We are proud to announce the release of our new compact 3D ultrasound probe for transperineal prostate fusion biopsies.
Check out the full press release: https://t.co/ltMWI92Aub
Salvage Cryotherapy versus radical prostatectomy: cryo has potentially lower risk of morbidity and acceptable intermediate-term oncological efficacy for radioreccurent PCa patients https://t.co/93LED2MDDx
KOELIS is proud to partner with Urology Times to spread the word about our cutting-edge prostate cancer screening solutions using our Trinity system.
Learn more about KOELIS and our partnership with Urology Times by watching the Viewpoints video series!
https://t.co/dqYJYenXnS
Buckle up, here comes AI for prostate MRI (no surprise). Impressive effort/findings.
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI) - The Lancet Oncology https://t.co/mR0HwNydCM
📢 Calling all urologists practicing focal therapy! Join and support the Focal Therapy Registry with the aim of capturing high-quality data. Your contribution is vital for promoting ablation therapies.
14 well-known centers are already onboard!
#ProstateCancer#FocalTherapy
The largest five-year oncological outcomes study for primary partial gland #cryoablation reveals a 91% freedom-from-failure rate in intermediate-risk #prostatecancer.
Learn more with study investigators Drs. Herbert Lepor and James Wysock: https://t.co/8seA1FSWcv
Save the date for #FOCAL2024! October 17-19 at the Manchester Grand Hyatt San Diego. Mark your calendar to join us for 3 days of outstanding CME content with the world's leading experts in #FocalTherapy!
Learn More: https://t.co/OXnw3W2OlH
@arvinkgeorge@AbhinavSidana